- Home
- ZVRA vs SANA Comparison
ZVRA vs SANA Comparison
Compare ZVRA & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- SANA
- Stock Information
- Founded
- ZVRA 2006
- SANA 2018
- Country
- ZVRA United States
- SANA United States
- Employees
- ZVRA N/A
- SANA N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- SANA Medicinal Chemicals and Botanical Products
- Sector
- ZVRA Health Care
- SANA Health Care
- Exchange
- ZVRA Nasdaq
- SANA Nasdaq
- Market Cap
- ZVRA 481.7M
- SANA 719.5M
- IPO Year
- ZVRA 2015
- SANA 2021
- Fundamental
- Price
- ZVRA $12.34
- SANA $4.18
- Analyst Decision
- ZVRA Strong Buy
- SANA Strong Buy
- Analyst Count
- ZVRA 9
- SANA 6
- Target Price
- ZVRA $23.25
- SANA $10.00
- AVG Volume (30 Days)
- ZVRA 1.0M
- SANA 6.4M
- Earning Date
- ZVRA 08-12-2025
- SANA 08-07-2025
- Dividend Yield
- ZVRA N/A
- SANA N/A
- EPS Growth
- ZVRA N/A
- SANA N/A
- EPS
- ZVRA N/A
- SANA N/A
- Revenue
- ZVRA $40,588,000.00
- SANA N/A
- Revenue This Year
- ZVRA $292.31
- SANA N/A
- Revenue Next Year
- ZVRA $78.65
- SANA N/A
- P/E Ratio
- ZVRA N/A
- SANA N/A
- Revenue Growth
- ZVRA 46.47
- SANA N/A
- 52 Week Low
- ZVRA $5.45
- SANA $1.26
- 52 Week High
- ZVRA $12.55
- SANA $7.40
- Technical
- Relative Strength Index (RSI)
- ZVRA 84.06
- SANA 79.28
- Support Level
- ZVRA $8.58
- SANA $2.60
- Resistance Level
- ZVRA $12.37
- SANA $4.37
- Average True Range (ATR)
- ZVRA 0.51
- SANA 0.34
- MACD
- ZVRA 0.31
- SANA 0.12
- Stochastic Oscillator
- ZVRA 98.47
- SANA 89.39
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.